Seok Jae Huh

Clinical significance of coagulation factors in operable colorectal cancer

Suee Lee, Seok Jae Huh, Sung Yong Oh et al. · Oncology Letters · 2017 · 70 citations · Full text

Medicine, Oncology, Surgery +17

D‐1553: A novel <scp>KRAS^G12C</scp> inhibitor with potent and selective cellular and in vivo antitumor activity

Zhe Shi, Jifang Weng, Haotao Niu et al. · Cancer Science · 2023 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

rhEGF Treatment Improves EGFR Inhibitor-Induced Skin Barrier and Immune Defects

Ji Min Kim, Jun Ho Ji, Young Saing Kim et al. · Cancers · 2020 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation

Dan‐Yun Ruan, Haoxiang Wu, Ye Xu et al. · Signal Transduction and Targeted Therapy · 2025 · 19 citations · Full text

Medicine, Oncology, Pharmacology +16

A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis

Dong Hyun Lee, Sung Yong Oh, Yu Rim Lee et al. · Cancer Research and Treatment · 2011 · 18 citations · Full text

Medicine, Oncology, Pharmacotherapy +15